ArticleInternational dental journal2026
A Novel Nonsense Variant in TBX15 Transcription Factor Suggests an Expanded Genetic Spectrum Of Submucous Cleft Palate.
Article in International dental journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Cousin Syndrome Due to TBX15 Gene Variants: Three Novel Cases and Review of the Literature.Clinical genetics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
INTRODUCTION AND
aimsSubmucous cleft palate (SMCP) is a congenital craniofacial malformation. While TBX22 is a known pathogenic gene, the potential role of TBX15 in SMCP remains unclear. This study aimed to investigate the genetic etiology of SMCP in a multigenerational family and explore the possible involvement of TBX15.
methodsWhole-exome sequencing (WES) was performed on a 4-generation Chinese family with SMCP. Functional characterization of the identified variant was conducted through protein localization and transcriptional activity assays. Furthermore, single-nucleus RNA sequencing (snRNA-seq) of developing mouse palate tissues and immunofluorescence staining were employed to analyse the expression and role of Tbx15 during palatogenesis.
resultsWES identified a heterozygous nonsense variant (c.C1231T, p.Gln411Ter) in the terminal exon of TBX15. This variant is predicted to produce a truncated protein. Functional analyses demonstrated that the mutant TBX15 protein exhibits aberrant cytoplasmic mis-localization and significantly reduced transcriptional activity. SnRNA-seq revealed high expression of Tbx15 in a specific mesenchymal cell population during mouse palate development, with the highest expression observed at E15.5. Immunofluorescence confirmed colocalization of TBX15 with osteogenic markers in the developing palate, implicating it in intramembranous bone formation.
conclusionThis study provides the first evidence that a loss-of-function variant in TBX15 is associated with SMCP. The findings suggest that TBX15 plays a critical role in palatal osteogenesis, potentially through mechanisms overlapping with TBX22, and implicate TBX15 as a potential novel candidate gene for SMCP, suggesting a possible expansion of the genetic spectrum of this condition. CLINICAL RELEVANCE: The results suggest a potential expansion of the genetic spectrum of SMCP, offering new insights for molecular diagnosis and genetic counselling. Understanding TBX15's role in palate bone development may inform future research into therapeutic strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.